Elite Pharmaceuticals (ELTP) Selling, General & Administrative (2010 - 2026)
Elite Pharmaceuticals (ELTP) recorded Selling, General & Administrative of $3.55 million in fiscal Q1 2027 (quarter ended Jun 30, 2026), up 4.3% from $3.4 million a year earlier but down 53.9% from the prior quarter.
Elite Pharmaceuticals (ELTP) Selling, General & Administrative (2010 - 2026) Analysis & Trends
On a TTM basis, Elite Pharmaceuticals' Selling, General & Administrative came in at $17.74 million as of Jun 30, 2026, up 70.0% year-over-year; for FY2026 (ended Mar 31, 2026), it came in at $17.6 million, up 95.5% from FY2025.
- Annual Selling, General & Administrative has increased for five straight fiscal years, with a five-year compound annual growth rate of 39.6% (FY2021 to FY2026).
- Across earlier fiscal years, Selling, General & Administrative came in at $9 million in FY2025 (+26.0%), $7.15 million in FY2024 (+39.5%), $5.12 million in FY2023 (+14.7%) and $4.46 million in FY2022 (+34.3%).
- Quarterly Selling, General & Administrative has ranged from $765,520 in fiscal Q4 2023 to $7.7 million in fiscal Q4 2026 over the past five years.
- On a year-over-year basis, Selling, General & Administrative rose in six of the last eight quarters, with growth averaging 65.2%.
- Peak year-over-year performance for Selling, General & Administrative in the last five years was growth of 278.3% in fiscal Q4 2026, against a decline of 50.1% in fiscal Q4 2023 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $7.7 million (Q4 2026), $2.47 million (Q3 2026) and $4.03 million (Q2 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 6.29 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 3.24 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 5.65 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Elite Pharmaceuticals | 269.28 Mn | 150.96 Mn | 13.51 Mn | 3.55 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.55 Mn |
| Mar 31, 2026 | 7.70 Mn |
| Dec 31, 2025 | 2.47 Mn |
| Sep 30, 2025 | 4.03 Mn |
| Jun 30, 2025 | 3.40 Mn |
| Mar 31, 2025 | 2.03 Mn |
| Dec 31, 2024 | 2.72 Mn |
| Sep 30, 2024 | 2.27 Mn |
| Jun 30, 2024 | 1.97 Mn |
| Mar 31, 2024 | 2.24 Mn |
| Dec 31, 2023 | 1.71 Mn |
| Sep 30, 2023 | 1.53 Mn |
| Jun 30, 2023 | 1.66 Mn |
| Mar 31, 2023 | 765,520.00 |
| Dec 31, 2022 | 1.19 Mn |
| Sep 30, 2022 | 1.19 Mn |
| Jun 30, 2022 | 1.72 Mn |
| Mar 31, 2022 | 1.53 Mn |
| Dec 31, 2021 | 929,547.00 |
| Sep 30, 2021 | 925,872.00 |
Elite Pharmaceuticals Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=ELTP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "ELTP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=ELTP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();